RPS4XP17

Across TCGA pan-cancer cohorts, RPS4XP17 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated RPS4XP17 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RPS4XP17 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPS4XP17 expression acts as an unfavorable survival marker, although some lineages such as READ and KIRC show a favorable association.

ACC, LUAD, and READ are the cancer types where RPS4XP17 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Median	All	0.662	0.919	<.001	75	view →
LUAD	DFS	Tertile	III,IV	0.509	0.740	.006	40	view →
READ	OS	Tertile	All	0.983	0.827	.002	34	view →
SARC	OS	Median	All	0.399	0.623	<.001	28	view →
OV	OS	Median	All	0.275	0.370	.007	26	view →
KICH	DFS	Quartile	III,IV	0.388	1.000	.007	24	view →
KIRC	DFS	Median	III,IV	0.738	0.534	.013	20	view →
UCS	DFS	Median	IV	0.850	0.475	.023	18	view →
UCEC	DFS	Tertile	III,IV	0.672	0.435	.017	16	view →
SKCM	OS	Tertile	II,III,IV	0.826	0.621	.006	14	view →
DLBC	DFS	Quartile	II,III,IV	0.421	0.956	.013	13	view →
COAD	OS	Median	IV	0.335	0.687	.003	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

RPS4XP17–ACC (OS)

Open the ACC breakdown →